FR18C1029I2 - Dihydroquinazolines substituees a proprietes antivirales - Google Patents

Dihydroquinazolines substituees a proprietes antivirales

Info

Publication number: FR18C1029I2
Authority: FR; France
Prior art keywords: antiviral properties; dihydroquinazolines; substituted; substituted dihydroquinazolines; antiviral
Prior art date: 2003-05-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

FR18C1029C

Other languages

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Aicuris Anti Infectives Cures GmbH

Original Assignee

Aicuris Anti Infectives Cures GmbH

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-05-02

Filing date

2018-07-06

Publication date

2020-07-17

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33305099&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR18C1029(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2018-07-06 Application filed by Aicuris Anti Infectives Cures GmbH filed Critical Aicuris Anti Infectives Cures GmbH

2018-08-17 Publication of FR18C1029I1 publication Critical patent/FR18C1029I1/fr

2020-07-17 Application granted granted Critical

2020-07-17 Publication of FR18C1029I2 publication Critical patent/FR18C1029I2/fr

Status Active legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/84—Nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

FR18C1029C 2003-05-02 2018-07-06 Dihydroquinazolines substituees a proprietes antivirales Active FR18C1029I2 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10319612A DE10319612A1 (de)	2003-05-02	2003-05-02	Substituierte Dihydrochinazoline
PCT/EP2004/004103 WO2004096778A1 (fr)	2003-05-02	2004-04-17	Dihydroquinazolines substituees a proprietes antivirales

Publications (2)

Publication Number	Publication Date
FR18C1029I1 FR18C1029I1 (fr)	2018-08-17
FR18C1029I2 true FR18C1029I2 (fr)	2020-07-17

Family

ID=33305099

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR18C1029C Active FR18C1029I2 (fr)	2003-05-02	2018-07-06	Dihydroquinazolines substituees a proprietes antivirales

Country Status (38)

Country	Link
US (4)	US7196086B2 (fr)
EP (1)	EP1622880B3 (fr)
JP (1)	JP4733631B2 (fr)
KR (1)	KR100927063B1 (fr)
CN (1)	CN100393706C (fr)
AR (1)	AR044078A1 (fr)
AT (1)	ATE355280T1 (fr)
AU (1)	AU2004233978B2 (fr)
BR (1)	BRPI0410029B8 (fr)
CA (1)	CA2524069C (fr)
CL (1)	CL2004000930A1 (fr)
CO (1)	CO5700764A2 (fr)
CY (2)	CY1106476T1 (fr)
DE (2)	DE10319612A1 (fr)
DK (1)	DK1622880T6 (fr)
EC (1)	ECSP056138A (fr)
EG (1)	EG25273A (fr)
ES (1)	ES2284007T7 (fr)
FR (1)	FR18C1029I2 (fr)
HN (1)	HN2004000146A (fr)
HU (2)	HUS1800018I1 (fr)
IL (1)	IL171513A (fr)
MA (1)	MA27794A1 (fr)
MX (1)	MXPA05011707A (fr)
MY (1)	MY144616A (fr)
NL (1)	NL300933I2 (fr)
NO (2)	NO333265B3 (fr)
NZ (1)	NZ543317A (fr)
PE (1)	PE20050145A1 (fr)
PL (1)	PL1622880T6 (fr)
PT (1)	PT1622880E (fr)
RU (1)	RU2360912C2 (fr)
SI (1)	SI1622880T1 (fr)
TW (1)	TWI335912B (fr)
UA (1)	UA82519C2 (fr)
UY (1)	UY28294A1 (fr)
WO (1)	WO2004096778A1 (fr)
ZA (1)	ZA200508710B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10319612A1 (de)	2003-05-02	2004-11-18	Bayer Healthcare Ag	Substituierte Dihydrochinazoline
DE10305785A1 (de) *	2003-02-12	2004-08-26	Bayer Healthcare Ag	Dihydrochinazoline
DE10320780A1 (de)	2003-05-09	2005-01-20	Bayer Healthcare Ag	Heterocyclyl-substituierte Dihydrochinazoline
DE10352499A1 (de) *	2003-11-11	2005-06-09	Bayer Healthcare Ag	Substituierte Dihydrochinazoline II
DE102004022672A1 (de)	2004-05-07	2005-11-24	Bayer Healthcare Ag	Substituierte Azachinazoline
DE102005027517A1 (de) *	2005-06-15	2006-12-21	Bayer Healthcare Ag	Verfahren zur Herstellung von Dihydrochinazolinen
DE102011101446A1 (de)	2011-05-10	2012-11-15	Aicuris Gmbh & Co. Kg	Herstellung von "Dense Bodies" (DB)
DE102012101659A1 (de) *	2012-02-29	2013-08-29	Aicuris Gmbh & Co. Kg	Salze eines Dihydrochinazolinderivats
DE102012101673A1 (de) *	2012-02-29	2013-08-29	Aicuris Gmbh & Co. Kg	Salze eines Dihydrochinazolinderivats
DE102012101680A1 (de) *	2012-02-29	2013-08-29	Aicuris Gmbh & Co. Kg	Pharmazeutische Zubereitung enthaltend ein antiviral wirksames Dihydrochinazolinderivat
PL3010891T3 (pl) *	2013-06-19	2019-11-29	Aicuris Anti Infective Cures Gmbh	Amorficzny letermowir i jego stałe preparaty farmaceutyczne do podawania doustnego
US9890128B2 (en)	2013-12-12	2018-02-13	Merck Sharp & Dohme Corp.	Process for making substituted quinazoline compounds
US10392353B2 (en) *	2015-11-24	2019-08-27	Merck Sharp & Dohme Corp.	Processes for making substituted quinazoline compounds using hydrogen bonding catalysts
CN109476677B (zh) *	2016-08-08	2024-06-07	辉诺生物医药科技（杭州）有限公司	抗hcmv病毒化合物
AU2019218150B2 (en)	2018-02-08	2021-05-13	Phaeno Therapeutics Co., Ltd.	Crystal form of 3,4-dihydrothieno[3,2-d]pyrimidine compound and preparation method therefor
EP3527209A1 (fr) *	2018-02-16	2019-08-21	UCB Biopharma SPRL	Dérivés pharmaceutiques de noyau hétérobicyclique 6,5
CA3112326A1 (fr)	2018-09-12	2020-03-19	Novartis Ag	Composes antiviraux de pyridopyrazinedione
WO2021061898A1 (fr)	2019-09-26	2021-04-01	Novartis Ag	Composés antiviraux de pyrazolopyridinone
UY39099A (es)	2020-02-27	2021-08-31	Aic246 Gmbh & Co Kg	2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5-(trifluorometil)fenil]-4h-quinazolin-4-il] acetato de sodio y composiciones farmacéuticas del mismo
UY39096A (es)	2020-02-27	2021-09-30	Aic246 Gmbh & Co Kg	Un método para producir una forma cristalina de 2-[(4s)-8- fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5- (trifluorometil)fenil]-4h-quinazolin-4-il]acetato de sodio trihidrato
AR121440A1 (es)	2020-02-27	2022-06-08	Aic246 Gmbh & Co Kg	Un método de preparación de 2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5-(trifluorometil)fenil]-4h-quinazolin-4-il] acetato de sodio monohidrato, dicho compuesto y el uso del mismo para el tratamiento de infecciones virales
UY39097A (es) *	2020-02-27	2021-09-30	Aic246 Gmbh & Co Kg	Sal de potasio del ácido 2-[(4s)-8-fluoro-2-[4-(3- metoxifenil)piperazin-1-il]-3-[2-metoxi-5- (trifluorometil)fenil]-4h-quinazolin-4-il]acético
UY39095A (es)	2020-02-27	2021-09-30	Aic246 Gmbh & Co Kg	Composiciones farmacéuticas que comprenden acetato de 2- [(4s)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5- (trifluorometil)fenil]-4h-quinazolin-4-il] e iones de sodio
EP3906929A1 (fr)	2020-05-08	2021-11-10	AiCuris GmbH & Co. KG	Letermovir pour son utilisation dans la prévention et le traitement des infections à coronavirus
US20230312485A1 (en)	2020-08-17	2023-10-05	Lupin Limited	A precipitation process for amorphous letermovir
CN115403528B (zh) *	2021-05-27	2025-01-07	南京正大天晴制药有限公司	无定形3,4-二氢喹唑啉衍生物的制备方法
CN114031560B (zh) *	2021-11-16	2022-10-04	山东诚创蓝海医药科技有限公司	一种来特莫韦钠盐的制备方法
AR128035A1 (es)	2021-12-21	2024-03-20	Aic246 Ag & Co Kg	Composiciones farmacéuticas que comprenden acetato de 2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5-(trifluorometil)fenil]-4h-quinazolin-4-il] e iones de potasio
CN118974026A (zh) *	2022-04-01	2024-11-15	上海迪赛诺化学制药有限公司	莱特莫韦中间体及其制备方法
CN115322157B (zh) *	2022-06-02	2023-12-05	浙江车头制药股份有限公司	来特莫韦中间体化合物及其制备方法和应用
CN117229223A (zh) *	2022-06-08	2023-12-15	苏州远智医药科技有限公司	一种杂环衍生物及其药物组合物、应用
WO2025133248A1 (fr)	2023-12-21	2025-06-26	Aic246 Ag & Co. Kg	Sels d'aminoalcool et d'aminoéther diastéréoisomères d'acide 2-[(4r,s)-8-fluoro-2-[4-(3-méthoxyphényl)pipérazin-1-yl]-3-[2-méthoxy-5-(trifluorométhyl)phényl]-3,4-dihydroquinazolin-4-yl]acétique et leur utilisation pour la séparation énantiomérique

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4320347A1 (de)	1993-06-19	1994-12-22	Boehringer Mannheim Gmbh	Quinazolin-Derivate und diese enthaltende Arzneimittel
US5854245A (en) *	1996-06-28	1998-12-29	Merck & Co., Inc.	Fibrinogen receptor antagonists
GB9718972D0 (en) *	1996-09-25	1997-11-12	Zeneca Ltd	Chemical compounds
DE19802437A1 (de)	1998-01-23	1999-07-29	Bayer Ag	Verwendung von substituierten Sulfonamiden als anitvirale Mittel und neue Stoffe
CA2321153A1 (fr)	1998-02-17	1999-08-19	Timothy D. Cushing	Antiviraux derives de pyrimidine
PL351374A1 (en)	1999-04-19	2003-04-07	Shionogi & Co	Sulfonamide derivatives having oxadiazole rings
DE19930075A1 (de)	1999-06-30	2001-01-04	Bayer Ag	Neue Amino- und Amidosulfonamide als antivirale Mittel
US6730682B2 (en) *	2000-07-12	2004-05-04	Pharmacia & Upjohn Company	Heterocycle carboxamides as antiviral agents
EP1325008B1 (fr) *	2000-07-31	2005-10-05	F. Hoffmann-La Roche Ag	Derives de la piperazine
EP1201765A3 (fr) *	2000-10-16	2003-08-27	Axxima Pharmaceuticals Aktiengesellschaft	Kinases cellulaires impliqués dans l'infection par cytomégalovirus et leur inhibition
JP4480941B2 (ja)	2001-04-19	2010-06-16	アイキュリス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング・ウント・コムパニー・コマンディットゲゼルシャフト	抗ウイルス剤としての新規アリールスルホンアミド
DE10138578A1 (de)	2001-08-06	2003-02-27	Bayer Ag	Heterocyclylarylsulfonamide
DE10251914A1 (de)	2002-11-08	2004-05-19	Bayer Ag	Substituierte Chinazoline
DE10319612A1 (de)	2003-05-02	2004-11-18	Bayer Healthcare Ag	Substituierte Dihydrochinazoline
DE10305785A1 (de) *	2003-02-12	2004-08-26	Bayer Healthcare Ag	Dihydrochinazoline
DE10320780A1 (de) *	2003-05-09	2005-01-20	Bayer Healthcare Ag	Heterocyclyl-substituierte Dihydrochinazoline
DE10352499A1 (de) *	2003-11-11	2005-06-09	Bayer Healthcare Ag	Substituierte Dihydrochinazoline II
KR100610731B1 (ko) *	2004-02-24	2006-08-09	한국과학기술연구원	Ｔ-형 칼슘 채널 차단제로서 유용한 ３,４-디히드로퀴나졸린유도체 및 그의 제조 방법
DE102004022672A1 (de)	2004-05-07	2005-11-24	Bayer Healthcare Ag	Substituierte Azachinazoline
EP1848698B1 (fr) *	2005-01-25	2013-03-13	Prolexys Pharmaceuticals, Inc.	Dérivés de quinoxaline en tant qu'agents contre des tumeurs
DE102005027517A1 (de)	2005-06-15	2006-12-21	Bayer Healthcare Ag	Verfahren zur Herstellung von Dihydrochinazolinen
ATE449097T1 (de) *	2005-07-21	2009-12-15	Hoffmann La Roche	Pyridoä2,3-düpyrimidin-2,4-diamin-verbindungen als ptpib-hemmer
DE102006009928A1 (de)	2006-03-03	2007-09-06	Aicuris Gmbh & Co. Kg	Substituierte Arylsulfonamide
DE102012101680A1 (de) *	2012-02-29	2013-08-29	Aicuris Gmbh & Co. Kg	Pharmazeutische Zubereitung enthaltend ein antiviral wirksames Dihydrochinazolinderivat
DE102012101659A1 (de) *	2012-02-29	2013-08-29	Aicuris Gmbh & Co. Kg	Salze eines Dihydrochinazolinderivats
DE102012101673A1 (de)	2012-02-29	2013-08-29	Aicuris Gmbh & Co. Kg	Salze eines Dihydrochinazolinderivats
PL3010891T3 (pl) *	2013-06-19	2019-11-29	Aicuris Anti Infective Cures Gmbh	Amorficzny letermowir i jego stałe preparaty farmaceutyczne do podawania doustnego

2003
- 2003-05-02 DE DE10319612A patent/DE10319612A1/de not_active Withdrawn
2004
- 2004-04-17 KR KR1020057020720A patent/KR100927063B1/ko not_active Expired - Lifetime
- 2004-04-17 AT AT04728119T patent/ATE355280T1/de active
- 2004-04-17 PT PT04728119T patent/PT1622880E/pt unknown
- 2004-04-17 UA UAA200511418A patent/UA82519C2/uk unknown
- 2004-04-17 BR BRPI0410029A patent/BRPI0410029B8/pt not_active IP Right Cessation
- 2004-04-17 EP EP04728119.1A patent/EP1622880B3/fr not_active Expired - Lifetime
- 2004-04-17 PL PL04728119T patent/PL1622880T6/pl unknown
- 2004-04-17 WO PCT/EP2004/004103 patent/WO2004096778A1/fr not_active Ceased
- 2004-04-17 MX MXPA05011707A patent/MXPA05011707A/es active IP Right Grant
- 2004-04-17 CN CNB2004800119284A patent/CN100393706C/zh not_active Expired - Lifetime
- 2004-04-17 AU AU2004233978A patent/AU2004233978B2/en active Active
- 2004-04-17 DK DK04728119.1T patent/DK1622880T6/da active
- 2004-04-17 NZ NZ543317A patent/NZ543317A/en not_active IP Right Cessation
- 2004-04-17 JP JP2006505178A patent/JP4733631B2/ja not_active Expired - Lifetime
- 2004-04-17 RU RU2005137276/04A patent/RU2360912C2/ru active
- 2004-04-17 ES ES04728119.1T patent/ES2284007T7/es active Active
- 2004-04-17 DE DE502004003052T patent/DE502004003052D1/de not_active Expired - Lifetime
- 2004-04-17 SI SI200430301T patent/SI1622880T1/sl unknown
- 2004-04-17 CA CA2524069A patent/CA2524069C/fr not_active Expired - Lifetime
- 2004-04-23 AR ARP040101391A patent/AR044078A1/es active IP Right Grant
- 2004-04-26 US US10/832,109 patent/US7196086B2/en not_active Ceased
- 2004-04-28 UY UY28294A patent/UY28294A1/es not_active IP Right Cessation
- 2004-04-29 MY MYPI20041603A patent/MY144616A/en unknown
- 2004-04-29 HN HN2004000146A patent/HN2004000146A/es unknown
- 2004-04-30 PE PE2004000432A patent/PE20050145A1/es active IP Right Grant
- 2004-04-30 TW TW093112100A patent/TWI335912B/zh active
- 2004-04-30 CL CL200400930A patent/CL2004000930A1/es unknown
2005
- 2005-10-20 IL IL171513A patent/IL171513A/en active IP Right Grant
- 2005-10-27 ZA ZA2005/08710A patent/ZA200508710B/en unknown
- 2005-10-29 EG EGNA2005000688 patent/EG25273A/xx active
- 2005-11-01 EC EC2005006138A patent/ECSP056138A/es unknown
- 2005-11-02 CO CO05111848A patent/CO5700764A2/es active IP Right Grant
- 2005-11-08 MA MA28581A patent/MA27794A1/fr unknown
- 2005-11-30 NO NO20055649A patent/NO333265B3/no active Protection Beyond IP Right Term
2007
- 2007-03-26 US US11/728,896 patent/US8513255B2/en active Active
- 2007-05-25 CY CY20071100709T patent/CY1106476T1/el unknown
2015
- 2015-04-09 US US14/682,512 patent/USRE46791E1/en active Active
2018
- 2018-04-17 NL NL300933C patent/NL300933I2/nl unknown
- 2018-04-21 HU HUS1800018C patent/HUS1800018I1/hu unknown
- 2018-06-15 HU HUS1800028C patent/HUS1800028I1/hu unknown
- 2018-06-29 CY CY2018019C patent/CY2018019I2/el unknown
- 2018-07-04 NO NO2018022C patent/NO2018022I1/no unknown
- 2018-07-06 FR FR18C1029C patent/FR18C1029I2/fr active Active
2020
- 2020-07-21 US US16/934,363 patent/USRE49698E1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
NO333265B1 (no)	2013-04-22
ZA200508710B (en)	2006-12-27
EG25273A (en)	2011-12-04
WO2004096778A1 (fr)	2004-11-11
BRPI0410029B1 (pt)	2019-12-31
UY28294A1 (es)	2004-11-30
PT1622880E (pt)	2007-06-04
NO20055649L (no)	2006-01-31
DK1622880T6 (da)	2018-06-18
USRE46791E1 (en)	2018-04-17
CY2018019I1 (el)	2018-12-12
AU2004233978A1 (en)	2004-11-11
KR20060009883A (ko)	2006-02-01
AU2004233978B2 (en)	2010-02-11
EP1622880A1 (fr)	2006-02-08
CY1106476T1 (el)	2012-01-25
PE20050145A1 (es)	2005-05-22
HUS1800018I1 (hu)	2018-05-28
SI1622880T1 (sl)	2007-08-31
HK1092463A1 (zh)	2007-02-09
US20050065160A1 (en)	2005-03-24
IL171513A (en)	2011-11-30
ES2284007T7 (es)	2018-06-20
USRE49698E1 (en)	2023-10-17
ES2284007T3 (es)	2007-11-01
MY144616A (en)	2011-10-14
ATE355280T1 (de)	2006-03-15
JP2006525249A (ja)	2006-11-09
EP1622880B1 (fr)	2007-02-28
DK1622880T3 (da)	2007-06-25
CA2524069A1 (fr)	2004-11-11
PL1622880T3 (pl)	2007-08-31
RU2005137276A (ru)	2006-07-27
BRPI0410029A (pt)	2006-04-25
CA2524069C (fr)	2011-11-08
HN2004000146A (es)	2008-06-24
CN100393706C (zh)	2008-06-11
CL2004000930A1 (es)	2005-03-18
ECSP056138A (es)	2006-04-19
EP1622880B3 (fr)	2018-05-23
PL1622880T6 (pl)	2018-08-31
US20070191387A1 (en)	2007-08-16
DE10319612A1 (de)	2004-11-18
JP4733631B2 (ja)	2011-07-27
CO5700764A2 (es)	2006-11-30
US7196086B2 (en)	2007-03-27
TWI335912B (en)	2011-01-11
FR18C1029I1 (fr)	2018-08-17
HUS1800028I1 (hu)	2018-07-30
CN1784390A (zh)	2006-06-07
MA27794A1 (fr)	2006-03-01
NL300933I2 (nl)	2018-04-26
NO333265B3 (no)	2019-06-03
MXPA05011707A (es)	2006-02-13
CY2018019I2 (el)	2018-12-12
TW200510343A (en)	2005-03-16
DE502004003052D1 (de)	2007-04-12
BRPI0410029B8 (pt)	2021-06-15
KR100927063B1 (ko)	2009-11-13
NO20055649D0 (no)	2005-11-30
NZ543317A (en)	2008-05-30
NO2018022I1 (no)	2018-07-04
AR044078A1 (es)	2005-08-24
US8513255B2 (en)	2013-08-20
UA82519C2 (uk)	2008-04-25
RU2360912C2 (ru)	2009-07-10

Publication	Publication Date	Title
FR18C1029I2 (fr)	2020-07-17	Dihydroquinazolines substituees a proprietes antivirales
DE602005015466D1 (de)	2009-08-27	Antivirale 4'-azidonucleoside
ATE363383T1 (de)	2007-06-15	Schlingenware
AT502792A5 (de)	2007-05-15	Düsenanpressvorrichtung
EP1596079A4 (fr)	2006-10-04	Pallier a glissement
DE112004000620D2 (de)	2005-12-22	Struktoguss
DE10355350A8 (de)	2006-11-09	Elektromodul
DE502004000672D1 (de)	2006-07-20	Pigmentpreparationen
ATA662003A (de)	2005-11-15	Trink-mundstück
ATE446959T1 (de)	2009-11-15	Chromenonindole
DE602004014793D1 (de)	2008-08-14	Acrylsolzusammensetzung
DE112004002227D2 (de)	2006-07-27	Nietverarbeitungsgerät
DE502004000518D1 (de)	2006-06-14	Mitgängergabelhubwagen
DE10394329D2 (de)	2006-10-05	Mäanderstent
ATE504278T1 (de)	2011-04-15	Hosenförmiger artikel mit verbesserter passform
ATE406350T1 (de)	2008-09-15	Prolinylarylacetamide
DE10329218B4 (de)	2007-05-16	Hotflue
DE112004001561D2 (de)	2006-06-01	Getriebene-Antreibseinheit
DE112004000759D2 (de)	2006-05-18	Banknote mit Schaltkreis
DE20317661U1 (de)	2005-03-24	Faltkleiderschrank
AT500001B8 (de)	2007-02-15	Münzscheideeinrichtung
DE502004001283D1 (de)	2006-10-05	Umsymmetrieranordnung
ATA1802003A (de)	2005-12-15	Verbundhonring
DE50307365D1 (de)	2007-07-12	Etui
FR2855873B1 (fr)	2007-06-22	Fusil a repetition